TRIM14 and hepatocellular carcinoma: To understand the impact of TRIM14 on HCC cell resistance to cisplatin, we performed qRT-PCR and Western blotting to determine the TRIM14 expression in cisplatin (DDP)-resistant HCC cells (DDP-R).